The Bush campaign failed in its efforts to mute the impact of gender gap issues such as abortion rights and gun control in the presidential campaign.
Concerned about the power of women voters, Republicans tried to hide Bush's opposition to women's rights issues and to appeal to women on the basis of his "compassionate conservatism."
But FDA approval of mifepristone made the abortion issue unavoidable. Before RU 486 was approved, Bush had stated that he as President would take actions to oppose the medication's availability. But, during the October 2nd debate - four days after the drug's approval and where he faced Vice President Al Gore who strongly favored abortion rights and women's access to RU 486 - Bush said that he did not think that the President would have the power to stop the drug from being made available. A few days later his campaign tried to clarify the issue saying that Bush would sign into law Congressional legislation placing restrictions on RU 486 distribution.
The Bush campaign also tried to confuse women voters with a "W for Women" tour, featuring former First Lady Barbara Bush.
Ultimately, however, Bush could not hide from the gender gap. In state after state and demographic subgroup after demographic subgroup, the majority of women rejected Bush. Overall, 10% fewer women than men voted for Bush - a gender gap against Bush even greater than the 1980 gender gap against Reagan. In every single state - with the exception of North Dakota - far fewer women than men supported Bush. (In North Dakota, Bush won 61% of women's votes and 60% of men's votes.)
Bush lost younger women. Only 42% percent of women aged 18-29 supported Bush, compared with 51% of men, for a 9-point gender gap. And he lost older women, who gave him only 42% of their votes, while he received support from 53% of men over 60 years old. Bush's support among unmarried women (38%), Black women (6%), women college graduates (40%), and women without high school diplomas (37%) was extremely low.
Despite the failure of the Democratic Party to feature gender gap issues in their campaign, many women voters understood the differences between the two candidates and voted accordingly.
12/12/2013 Feminist Majority Celebrates Introduction of Family and Medical Insurance Leave Act (FAMILY Act) - WASHINGTON -- Feminist Majority today celebrates and applauds Congresswoman Rosa DeLauro (D-CT) and Senator Kirsten Gillibrand (D-NY) for introducing the critically-needed paid family medical leave legislation.
The Family and Medical Insurance Leave Act (FAMILY Act) will allow workers to take paid time off to address a serious illness of their own, a spouse, parent or child or to care for a new baby or adopted child. . . .
12/11/2013 Human Rights Day Celebrated Around The World - Yesterday marked International Human Rights Day, a day to celebrate human rights advances and to assess the challenges that lie ahead in protecting them.
"The fundamentals for protecting and promoting human rights are largely in place: these include a strong and growing body of international human rights law and standards, as well as institutions to interpret the laws, monitor compliance and apply them to new and emerging human rights issues," said United Nations High Commissioner for Human Rights Navi Pillay in a statement. . . .
12/11/2013 UConn Under Federal Investigation For Mishandling Sexual Assault Cases - The US Department of Education's Office for Civil Rights (OCR) informed the University of Connecticut on Monday that it will investigate the school for allegedly mishandling sexual assault cases and violating Title IX, the federal law that requires all recipients of federal financial assistance for education programs and activities to prohibit sex discrimination and sexual harassment [PDF].
The investigation was sparked after seven women filed a formal complaint in October alleging that UConn had failed to protect them from sexual assault and exposed them to a sexually hostile environment.One woman says her attacker was expelled from campus but later readmitted without her knowledge. . . .